Analysis And Treatment On Hospitalited Patients With Acute Phase Of Cerebrovascular Diseases Complicated By Intrapulmonary Infection Of Bacteria Strains In Different Seasons

Objective: To explore the susceptible factors of infectionin hospital. the pathogenic features and features ofpathogens in different seasons and treatment inhospitalized patients with cerebrovascular diseases.Methods: In Affiliated Hospital of Beihua University, 108hospitalized patiends with cerebrovascular diseasescomplicated by intrapulmonary infection were randomlydivided into groups; the types of cerebrovasculardisease, seasons of onset. the varieties of pathogenicbacteria were sytematically analyzed; and the sensitivityexperiments or treatments on each variety of bacteria withdifferent antibiotics were condacted.Results: In 23 cases (cerebral hemorrhage 17 cases,cerebral thrombosis 6 cases) with onset in spring, thecommon pathogen was Klebsiella pneumoniae. In 16 cases(cerebral hemorrhage 10 cases cerebral thrombosis 6 cases)with onset in summer, the common pathogen wasAerobacter cloacae. In 26 case (cerebral hemorrhage 22cases, cerebral thrombosis 4 cases) with onset inautumn, the common pathogens were Pseudomonasaeruginosa and Aerobacter cloacae. In 43 cases (cerebral hemorrhage 34 cases, cerebral thrombosis 9 cases) withonset in winter, the common pathogens were Klebsiellapneumonia and Pseudomonas aeraginosa. On the basis ofstrictly complying with the principle of clinicalmedication, no signifcant difference was found in theapplication of antibacterials in this research.Conclusion: In hospitalized patients with cerebravasculardiseases in our hospital complicated by intrapulmonaryinfection, the incidence was the highest in winter, the nextwas in autumn and spring, and the lowest was insummer. According to the frequency of infection, thesusceptible bacteria variety was Klebsiella, the next wasPseudomonas aeruginosa, and Aerobacter cloacae, whichwere more susceptible to antibiotics Impinem,Cefatazidime, Aztreonam respectively with satisfactorytherapeutic effects.